TEMPESTINI, ALESSIO
TEMPESTINI, ALESSIO
Aponecrosis: morphologic and biochemical exploration of a syncretic process of cell death sharing apoptosis andnecrosis.
2000 Formigli L.; Papucci L.; Tani A.; Schiavone N.; Tempestini A.; Orlandini G. E.; Capaccioli S.; Zecchi Orlandini S.
Apoptosis is associated with early modifications of bcl-2 mRNA AU-binding proteins.
2001 Donnini M.; Lapucci A.; Papucci L.; Witort E.; Tempestini A.; Brewer G.; Bevilacqua A.; Nicolin A.; Capaccioli S.; Schiavone N.
Apoptosis shifts to necrosis via intermediate types of cell death by a mechanism depending on c-myc and bcl-2 expression
2004 Papucci L; Formigli L; Schiavone N; Tani A; Donnini M; Lapucci A; Perna F; Tempestini A; Witort E; Morganti M; Nosi D; Orlandini GE; Orlandini SZ; Capaccioli S
AUF1 ia a bcl-2 ARE-binding protein involved in bcl-2 mRNA destabilization during apoptosis
2002 A.Lapucci; M.Donnini; L.Papucci; E.Witort; A.Tempestini; A.Nicolin; G.Brewer; N.Schiavone; S.Capaccioli
Coenzyme q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property.
2003 L. PAPUCCI; N. SCHIAVONE ; E. WITORT;M. DONNINI ;A. LAPUCCI ; A. TEMPESTINI ; L. FORMIGLI; S. ZECCHI-ORLANDINI ; G.E ORLANDINI ; G. CARELLA G; R. BRANCATO ; S. CAPACCIOLI
Colestasi intraepatica in corso di amiloidosi sistemica AL senza evidenza istologica di un coinvolgimento epatico: un caso di epatopatia tossica o una mancata diagnosi di amiloidosi epatica?
2012 Paudice, Nunzia; Farsetti, Silvia; Caroti, Leonardo; Bandini, Sandro; Ciuti, Gabriele; Tempestini, Alessio; Perfetto, Federico; Galli, Simone; Giabbani, Letizia; Caldini, Anna Lucia; Bergesio, Franco
Downregulation of bcl-2 expression in lymphoma cells by bcl-2 ARE-targeted modified, synthetic ribozyme.
2003 LUZI E.; PAPUCCI L.; N. SCHIAVONE; DONNINI M.; LAPUCCI A.; TEMPESTINI A.; WITORT E.; NICOLIN A.; CAPACCIOLI S.
Exercise Doppler echocardiography identifies preclinic asymptomatic pulmonary hypertension in systemic sclerosis.
2007 Pignone A; Mori F; Pieri F; Oddo A; Galeota G; Fiori G; Del Rosso A; Perfetto F; Becucci A; Livi R; Tempestini A; Benvenuti C; Gramigna L; Fedi R; Generini S; Minelli M; Cinelli M; Guiducci S; Arcangeli C; Conforti ML; Bernardo P; Cerinic MM
Impact of Targeting the Adenine- and Uracil-Rich Element of bcl-2 mRNA with Oligoribonucleotides on Apoptosis, Cell Cycle, and Neuronal Differentiation in SHSY-5Y Cells
2008 L.Papucci; E.Witort; A.M.Bevilacqua; M.Donnini; M.Lulli; E.Borchi; K.S.A.Khabar; A.Tempestini; A.Lapucci; N.Schiavone; A.Nicolin; S.Capaccioli
Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarciodosis
2006 MOGGI PIGNONE A; DEL ROSSO A; FIORI G; MATUCCI CERINIC M; BECUCCI A; TEMPESTINI A; LIVI R; GENERINI S; GRAMIGNA L; BENVENUTI C; A. CAROSSINO; CONFORTI L; PERFETTO F
MOLECULAR CHARACTERIZATION OF ESTABLISHED HUMAN COLON CARCINOMA CELL LINES (HCT-8) MADE RESISTANT TO 5-FLUOROURACIL BY DIFFERENT SELECTION SCHEDULES
2006 A. TEMPESTINI; B. CACIAGLI; M. MORGANTI; E. WITORT; S. NOBILI; L. PAPUCCI; N. SCHIAVONE; M. DONNINI; I. LANDINI; A. LAPUCCI; F. PERNA; M. LULLI; T. MAZZEI; A. SOBRERO; E. MINI; S. CAPACCIOLI
Molecular characterization of established human colorectal carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil (5-FU) by different selective schedules
2004 A. Tempestini; E. Witort; L. Papucci; N. Schiavone; M. Donnini; A. Lapucci; F. Perna; M. Morganti; B. Caciagli; I. Landini; A. Sobrero; E. Mini; S. Capaccioli
PHOSPHODIESTER OLIGONUCLEOTIDES INHIBIT MITOSIS AND TRIGGER APOPTOSIS BY A NON-ANTISENSE, P53-MEDIATED MECHANISM.
2002 L. PAPUCCI;N. SCHIAVONE; M. DONNINI; A. LAPUCCI; E. LUZI; A. TEMPESTINI; E. WITORT; S. CAPACCIOLI
Prevention of retinal cell apoptosis by antisense modified oligoribonucleotides that upregulate Bcl-2 expression by targeting a Bcl-2 mRNA destablilizing element (ARE)
2003 Carella G; Tempestini A; Papucci L; Schiavone N; Donnini M; Lapucci A; Witort E; Brancato R; Capaccioli S
Systemic amyloidosis: a challenge for the rheumatologist.
2010 Perfetto F; Moggi-Pignone A; Livi R; Tempestini A; Bergesio F; Matucci-Cerinic M
The mechanisms of apoptosis in biology and medicine: a new focus for ophthalmology
2002 Tempestini A; Schiavone N; Papucci L; Witort E; Lapucci A; Cutrì M; Donnini M; Capaccioli S
Therapeutic challenges for systemic sclerosis: facts and future targets.
2007 Matucci Cerinic M; Del Rosso A; Perfetto F; Livi R; Fiori G; Bartoli F; Blagojevic J; Tempestini A; Pignone A
“Antisense Oligonucleotides Modulating BCL-2 Expression”
2003 Capaccioli S.; Papucci L.; Schiavone N.; Donnini M.; Lapucci A.; Tempestini A.; Brancato R.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Aponecrosis: morphologic and biochemical exploration of a syncretic process of cell death sharing apoptosis andnecrosis. | 2000 | Formigli L.; Papucci L.; Tani A.; Schiavone N.; Tempestini A.; Orlandini G. E.; Capaccioli S.; Zecchi Orlandini S. | |
Apoptosis is associated with early modifications of bcl-2 mRNA AU-binding proteins. | 2001 | Donnini M.; Lapucci A.; Papucci L.; Witort E.; Tempestini A.; Brewer G.; Bevilacqua A.; Nicolin A.; Capaccioli S.; Schiavone N. | |
Apoptosis shifts to necrosis via intermediate types of cell death by a mechanism depending on c-myc and bcl-2 expression | 2004 | Papucci L; Formigli L; Schiavone N; Tani A; Donnini M; Lapucci A; Perna F; Tempestini A; Witort E; Morganti M; Nosi D; Orlandini GE; Orlandini SZ; Capaccioli S | |
AUF1 ia a bcl-2 ARE-binding protein involved in bcl-2 mRNA destabilization during apoptosis | 2002 | A.Lapucci; M.Donnini; L.Papucci; E.Witort; A.Tempestini; A.Nicolin; G.Brewer; N.Schiavone; S.Capaccioli | |
Coenzyme q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property. | 2003 | L. PAPUCCI; N. SCHIAVONE ; E. WITORT;M. DONNINI ;A. LAPUCCI ; A. TEMPESTINI ; L. FORMIGLI; S. ZECCHI-ORLANDINI ; G.E ORLANDINI ; G. CARELLA G; R. BRANCATO ; S. CAPACCIOLI | |
Colestasi intraepatica in corso di amiloidosi sistemica AL senza evidenza istologica di un coinvolgimento epatico: un caso di epatopatia tossica o una mancata diagnosi di amiloidosi epatica? | 2012 | Paudice, Nunzia; Farsetti, Silvia; Caroti, Leonardo; Bandini, Sandro; Ciuti, Gabriele; Tempestini, Alessio; Perfetto, Federico; Galli, Simone; Giabbani, Letizia; Caldini, Anna Lucia; Bergesio, Franco | |
Downregulation of bcl-2 expression in lymphoma cells by bcl-2 ARE-targeted modified, synthetic ribozyme. | 2003 | LUZI E.; PAPUCCI L.; N. SCHIAVONE; DONNINI M.; LAPUCCI A.; TEMPESTINI A.; WITORT E.; NICOLIN A.; CAPACCIOLI S. | |
Exercise Doppler echocardiography identifies preclinic asymptomatic pulmonary hypertension in systemic sclerosis. | 2007 | Pignone A; Mori F; Pieri F; Oddo A; Galeota G; Fiori G; Del Rosso A; Perfetto F; Becucci A; Livi R; Tempestini A; Benvenuti C; Gramigna L; Fedi R; Generini S; Minelli M; Cinelli M; Guiducci S; Arcangeli C; Conforti ML; Bernardo P; Cerinic MM | |
Impact of Targeting the Adenine- and Uracil-Rich Element of bcl-2 mRNA with Oligoribonucleotides on Apoptosis, Cell Cycle, and Neuronal Differentiation in SHSY-5Y Cells | 2008 | L.Papucci; E.Witort; A.M.Bevilacqua; M.Donnini; M.Lulli; E.Borchi; K.S.A.Khabar; A.Tempestini; A.Lapucci; N.Schiavone; A.Nicolin; S.Capaccioli | |
Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarciodosis | 2006 | MOGGI PIGNONE A; DEL ROSSO A; FIORI G; MATUCCI CERINIC M; BECUCCI A; TEMPESTINI A; LIVI R; GENERINI S; GRAMIGNA L; BENVENUTI C; A. CAROSSINO; CONFORTI L; PERFETTO F | |
MOLECULAR CHARACTERIZATION OF ESTABLISHED HUMAN COLON CARCINOMA CELL LINES (HCT-8) MADE RESISTANT TO 5-FLUOROURACIL BY DIFFERENT SELECTION SCHEDULES | 2006 | A. TEMPESTINI; B. CACIAGLI; M. MORGANTI; E. WITORT; S. NOBILI; L. PAPUCCI; N. SCHIAVONE; M. DONNINI; I. LANDINI; A. LAPUCCI; F. PERNA; M. LULLI; T. MAZZEI; A. SOBRERO; E. MINI; S. CAPACCIOLI | |
Molecular characterization of established human colorectal carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil (5-FU) by different selective schedules | 2004 | A. Tempestini; E. Witort; L. Papucci; N. Schiavone; M. Donnini; A. Lapucci; F. Perna; M. Morganti; B. Caciagli; I. Landini; A. Sobrero; E. Mini; S. Capaccioli | |
PHOSPHODIESTER OLIGONUCLEOTIDES INHIBIT MITOSIS AND TRIGGER APOPTOSIS BY A NON-ANTISENSE, P53-MEDIATED MECHANISM. | 2002 | L. PAPUCCI;N. SCHIAVONE; M. DONNINI; A. LAPUCCI; E. LUZI; A. TEMPESTINI; E. WITORT; S. CAPACCIOLI | |
Prevention of retinal cell apoptosis by antisense modified oligoribonucleotides that upregulate Bcl-2 expression by targeting a Bcl-2 mRNA destablilizing element (ARE) | 2003 | Carella G; Tempestini A; Papucci L; Schiavone N; Donnini M; Lapucci A; Witort E; Brancato R; Capaccioli S | |
Systemic amyloidosis: a challenge for the rheumatologist. | 2010 | Perfetto F; Moggi-Pignone A; Livi R; Tempestini A; Bergesio F; Matucci-Cerinic M | |
The mechanisms of apoptosis in biology and medicine: a new focus for ophthalmology | 2002 | Tempestini A; Schiavone N; Papucci L; Witort E; Lapucci A; Cutrì M; Donnini M; Capaccioli S | |
Therapeutic challenges for systemic sclerosis: facts and future targets. | 2007 | Matucci Cerinic M; Del Rosso A; Perfetto F; Livi R; Fiori G; Bartoli F; Blagojevic J; Tempestini A; Pignone A | |
“Antisense Oligonucleotides Modulating BCL-2 Expression” | 2003 | Capaccioli S.; Papucci L.; Schiavone N.; Donnini M.; Lapucci A.; Tempestini A.; Brancato R. |